Brought to you by:
RapidAI earns US FDA clearance for AI-driven aortic measurement and surveillance product
RapidAI today announced the US Food and Drug Administration (FDA) clearance of Aortic Management, part of Rapid Aortic, which the company describes as “a comprehensive deep clinical AI [artificial intelligence] solution designed to transform the acute assessment and longitudinal management…
Final patient treated in Cook’s Zenith Fenestrated+ endovascular graft clinical study
Cook Medical has enrolled the final patient in the global clinical study of its Zenith Fenestrated+ endovascular graft (ZFEN+), signifying completion of patient recruitment in the pivotal study. The investigational ZFEN+ clinical study is being conducted under an Investigational Device Exemption…
Gore announces MDR expanded indication for the Viabahn VBX balloon-expandable endoprosthesis as a bridging stent
Gore today announced CE-mark approval of an expanded indication for the Gore Viabahn VBX balloon-expandable endoprosthesis (VBX stent graft) when used as a bridging stent with branched and fenestrated aortic endografts in the treatment of aortic aneurysms involving the renal…
Endospan completes enrolment of primary arm in TRIOMPHE IDE clinical study
Endospan today announced the completion of enrolment for the primary arm of its TRIOMPHE investigational device exemption (IDE) clinical study investigating the Nexus aortic arch stent graft. The study is evaluating the safety and efficacy of the device for the…
Cook Medical creates custom-made aortic device for fenestrated FET procedure
Cook Medical this week announced that it has created a custom-made device for the frozen elephant trunk (FET) aortic procedure. A press release details that, earlier this year, cardiothoracic surgeon François Dagenais, MD, from the Quebec Heart and Lung Institute…
New ESC guidelines combine peripheral arterial and aortic diseases for first time, emphasising interconnectivity of whole arterial system
The European Society of Cardiology (ESC) has today published its 2024 guidelines for the management of peripheral arterial and aortic diseases (PAAD), evaluating these vascular conditions together as part of the same cardiovascular system. The guidelines are aimed at cardiologists,…
Physician-modified endografts ‘safe and effective’ for thoracoabdominal and complex AAA repair
Researchers have reported a 94% technical success rate among other key findings from a recent international, multicentre, single-arm cohort study of physician-modified endografts (PMEGs) for thoracoabdominal and complex abdominal aortic aneurysm (AAA) repair. The work has been published in the…
ESVS 2024 clinical practice guidelines on the management of abdominal aortoiliac artery aneurysms—what’s new?
The updated European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines for the care of patients with aneurysms of the abdominal aorta and iliac arteries, have been published online this month in European Journal of Vascular and Endovascular Surgery,…
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium presentation delivered by Kevin Mani (Uppsala University, Uppsala, Sweden) at the 2023 Charing Cross (CX) International…